NYSE:EVHC - Envision Healthcare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$43.09 +0.17 (+0.40 %)
(As of 05/24/2018 09:06 AM ET)
Previous Close$42.92
Today's Range$42.6401 - $43.19
52-Week Range$23.77 - $64.00
Volume1.50 million shs
Average Volume2.92 million shs
Market Capitalization$5.20 billion
P/E Ratio17.38
Dividend YieldN/A
Beta0.43

About Envision Healthcare (NYSE:EVHC)

Envision Healthcare logoEnvision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The company also offers ambulatory surgical centers (ASCs) services that provide surgical procedures across multiple specialties, including gastroenterology, ophthalmology, orthopedics, and others. It operated 264 ASCs in 35 states and the District of Columbia. In addition, it provides surgery services, such as management, oversight, and surgeon staffing for trauma surgery services; offers direct patient care and care coordination by clinicians outside the acute care setting through physician-led post-acute care services; and operates office-based medical practices that primarily focus on women's health, as well as provides physician staffing and related management services. Further, it offers medical transportation services in 41 states and the District of Columbia. The company offers its clinical solutions for health systems, payors, providers, and patients. Envision Healthcare Corporation was founded in 1992 and is based in Nashville, Tennessee.

Receive EVHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EVHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
SymbolNYSE:EVHC
CUSIPN/A
Phone615-665-1283

Debt

Debt-to-Equity Ratio0.65
Current Ratio2.27
Quick Ratio2.25

Price-To-Earnings

Trailing P/E Ratio17.38
Forward P/E Ratio12.71
P/E Growth0.98

Sales & Book Value

Annual Sales$12.18 billion
Price / Sales0.43
Cash Flow$6.2359 per share
Price / Cash6.91
Book Value$58.53 per share
Price / Book0.74

Profitability

EPS (Most Recent Fiscal Year)$2.48
Net Income$-228,000,000.00
Net Margins1.41%
Return on Equity4.59%
Return on Assets1.97%

Miscellaneous

Employees69,300
Outstanding Shares121,130,000

Envision Healthcare (NYSE:EVHC) Frequently Asked Questions

What is Envision Healthcare's stock symbol?

Envision Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVHC."

How will Envision Healthcare's stock buyback program work?

Envision Healthcare declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, September 19th 2017, which allows the company to repurchase $250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its shares are undervalued.

How were Envision Healthcare's earnings last quarter?

Envision Healthcare (NYSE:EVHC) released its quarterly earnings data on Monday, May, 7th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.64 by $0.07. The firm earned $2.08 billion during the quarter, compared to analyst estimates of $2.02 billion. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The company's revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.77 EPS. View Envision Healthcare's Earnings History.

When is Envision Healthcare's next earnings date?

Envision Healthcare is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Envision Healthcare.

What guidance has Envision Healthcare issued on next quarter's earnings?

Envision Healthcare updated its FY18 earnings guidance on Monday, May, 7th. The company provided EPS guidance of $3.49-3.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.59. The company issued revenue guidance of $8.35-8.53 billion, compared to the consensus revenue estimate of $8.41 billion.Envision Healthcare also updated its Q2 guidance to $0.83-0.90 EPS.

What price target have analysts set for EVHC?

14 brokerages have issued 1-year price targets for Envision Healthcare's shares. Their predictions range from $31.00 to $50.00. On average, they anticipate Envision Healthcare's share price to reach $40.75 in the next twelve months. View Analyst Ratings for Envision Healthcare.

What are Wall Street analysts saying about Envision Healthcare stock?

Here are some recent quotes from research analysts about Envision Healthcare stock:
  • 1. According to Zacks Investment Research, "Envision Healthcare’s first-quarter earnings beat the Zacks Consensus Estimate by 14%. The bottom line was however, down 5.8% year over year. Better-than-expected earnings were driven by revenue growth at the company’s Physicians Services segment. The stock has outperformed the industry in the past six months. The company has taken some discrete actions to improve its operating performance. It is optimistic about the physician services market, witnessing consolidation. Also, the divestiture of its AMR business will help the company focus on its core operations. However, the company suffers high leverage, leading to increased interest ratio. Its operating expense is exceeding the revenue growth and exerting pressure on the operating margins." (5/11/2018)
  • 2. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $46 based on an improving financial outlook given restructuring and easing utilization headwinds. The company characterized guidance as highly visible and not heroic. As such, we recommend continued exposure as utilization headwinds dissipate and the operational improvement plan takes hold. Key positive: High visibility into 2018 guidance: The low-end of 2018 adj-EBITDA of $960M is 87% in hand when annualizing 4Q’17. M&A from 2017 and 2018 should contribute an incremental $10-$15M and $20-$30M, respectively, bringing visibility up to 92% coverage at the low-end. Organic growth and further expense benefits from operational improvements would be the last leg in getting to guidance. Key negative: Consolidated organic growth rate lowered to 2-5% (was 3-6%) taking into account a softer utilization environment." (2/28/2018)
  • 3. Cantor Fitzgerald analysts commented, "Revised 2018 estimates. We are lowering our 2018 adjusted EPS estimate to $3.75 from $3.95 and bringing down our adjusted 2018 EBITDA estimate to $950.6 million from $982 million to account for slightly higher seasonality, primarily in terms of salary, wages and benefits, which account for the majority of EVHC’s operating expenses. Our new estimate is just below the $960 million midpoint of management’s potential 2018 performance, as outlined in a presentation last November, but it remains above the $925.1 million FactSet consensus." (2/21/2018)

Are investors shorting Envision Healthcare?

Envision Healthcare saw a increase in short interest during the month of April. As of April 13th, there was short interest totalling 28,150,685 shares, an increase of 15.1% from the March 30th total of 24,458,190 shares. Based on an average daily volume of 2,547,743 shares, the short-interest ratio is currently 11.0 days. Approximately 23.8% of the company's shares are short sold.

Who are some of Envision Healthcare's key competitors?

Who are Envision Healthcare's key executives?

Envision Healthcare's management team includes the folowing people:
  • Mr. William A. Sanger, Exec. Chairman (Age 68)
  • Mr. Christopher A. Holden, CEO, Pres & Director (Age 54)
  • Ms. Claire M. Gulmi, Advisor (Age 64)
  • Mr. Kevin D. Eastridge, Exec. VP & CFO (Age 53)
  • Mr. Karey Lynn Witty, Exec. VP & COO (Age 53)

Has Envision Healthcare been receiving favorable news coverage?

News articles about EVHC stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Envision Healthcare earned a news sentiment score of 0.09 on Accern's scale. They also assigned media headlines about the company an impact score of 47.54 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Envision Healthcare's major shareholders?

Envision Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.56%), Dimensional Fund Advisors LP (1.97%), Roystone Capital Management LP (1.75%), Neuberger Berman Group LLC (1.46%), JPMorgan Chase & Co. (1.39%) and Royal Bank of Canada (1.39%). Company insiders that own Envision Healthcare stock include John Thomas Gawaluck and Robert Jon Coward. View Institutional Ownership Trends for Envision Healthcare.

Which institutional investors are selling Envision Healthcare stock?

EVHC stock was sold by a variety of institutional investors in the last quarter, including Citigroup Inc., Guggenheim Capital LLC, State of Tennessee Treasury Department, Honeywell International Inc., Clearline Capital LP, Dimensional Fund Advisors LP, Segall Bryant & Hamill LLC and BlackRock Inc.. View Insider Buying and Selling for Envision Healthcare.

Which institutional investors are buying Envision Healthcare stock?

EVHC stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Roystone Capital Management LP, Boston Partners, UBS Group AG, Farallon Capital Management LLC, FIL Ltd, 12th Street Asset Management Company LLC and Neuberger Berman Group LLC. View Insider Buying and Selling for Envision Healthcare.

How do I buy shares of Envision Healthcare?

Shares of EVHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Envision Healthcare's stock price today?

One share of EVHC stock can currently be purchased for approximately $43.09.

How big of a company is Envision Healthcare?

Envision Healthcare has a market capitalization of $5.20 billion and generates $12.18 billion in revenue each year. The company earns $-228,000,000.00 in net income (profit) each year or $2.48 on an earnings per share basis. Envision Healthcare employs 69,300 workers across the globe.

How can I contact Envision Healthcare?

Envision Healthcare's mailing address is 1A BURTON HILLS BOULEVARD, NASHVILLE TN, 37215. The company can be reached via phone at 615-665-1283 or via email at [email protected]


MarketBeat Community Rating for Envision Healthcare (EVHC)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  474 (Vote Outperform)
Underperform Votes:  249 (Vote Underperform)
Total Votes:  723
MarketBeat's community ratings are surveys of what our community members think about Envision Healthcare and other stocks. Vote "Outperform" if you believe EVHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVHC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Envision Healthcare (NYSE:EVHC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for Envision Healthcare in the last 12 months. Their average twelve-month price target is $40.75, suggesting that the stock has a possible downside of 5.43%. The high price target for EVHC is $50.00 and the low price target for EVHC is $31.00. There are currently 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.572.572.602.75
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $40.75$40.6071$39.8214$45.8462
Price Target Upside: 5.43% downside13.33% upside6.11% upside56.74% upside

Envision Healthcare (NYSE:EVHC) Consensus Price Target History

Price Target History for Envision Healthcare (NYSE:EVHC)

Envision Healthcare (NYSE:EVHC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/9/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$46.00 ➝ $48.00MediumView Rating Details
4/11/2018Robert W. BairdSet Price TargetBuy$50.00HighView Rating Details
4/11/2018Jefferies GroupSet Price TargetBuy$46.00HighView Rating Details
3/2/2018MizuhoSet Price TargetHold$38.00LowView Rating Details
3/1/2018Royal Bank of CanadaReiterated RatingBuy$48.00LowView Rating Details
3/1/2018SunTrust BanksBoost Price TargetPositive ➝ Buy$45.00LowView Rating Details
2/28/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$37.00 ➝ $40.00HighView Rating Details
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Positive$36.00 ➝ $43.50LowView Rating Details
1/10/2018StephensReiterated RatingHold$34.00LowView Rating Details
12/13/2017Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$35.00LowView Rating Details
11/14/2017KeyCorpSet Price TargetBuy$40.00N/AView Rating Details
11/2/2017OppenheimerLower Price TargetOutperform$77.00 ➝ $40.00N/AView Rating Details
11/2/2017CitigroupDowngradeBuy ➝ Neutral$31.00N/AView Rating Details
11/2/2017Bank of AmericaDowngradeBuy ➝ Neutral$32.00N/AView Rating Details
3/21/2017BarclaysReiterated RatingOverweightLowView Rating Details
12/29/2016Raymond JamesReiterated RatingStrong-Buy$100.00 ➝ $90.00N/AView Rating Details
12/9/2016Goldman Sachs GroupInitiated CoverageBuyN/AView Rating Details
12/7/2016UBSUpgradeMarket Perform ➝ OutperformN/AView Rating Details
11/2/2016Wells Fargo & CoUpgradeMarket Perform ➝ OutperformN/AView Rating Details
(Data available from 5/24/2016 forward)

Earnings

Envision Healthcare (NYSE:EVHC) Earnings History and Estimates Chart

Earnings by Quarter for Envision Healthcare (NYSE:EVHC)

Envision Healthcare (NYSE:EVHC) Earnings Estimates

2018 EPS Consensus Estimate: $3.19
2019 EPS Consensus Estimate: $3.79
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.51$0.62$0.57
Q2 20184$0.75$0.83$0.79
Q3 20183$0.78$0.93$0.86
Q4 20183$0.94$1.00$0.97
Q1 20191$0.72$0.72$0.72
Q2 20191$0.95$0.95$0.95
Q3 20191$1.04$1.04$1.04
Q4 20191$1.08$1.08$1.08

Envision Healthcare (NYSE EVHC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/6/2018$0.88N/AView Earnings Details
5/7/2018Q1 2018$0.64$0.71$2.0158 billion$2.0770 billionViewN/AView Earnings Details
2/27/2018Q4 2017$0.45$0.59$1.9724 billion$2.0030 billionViewN/AView Earnings Details
10/31/2017Q3 2017$0.81$0.73$2.0337 billion$1.99 billionViewN/AView Earnings Details
8/7/2017Q2 2017$0.75$0.79$1.9551 billion$1.9470 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.69$0.69$2.5231 billion$1.8786 billionViewListenView Earnings Details
2/28/2017Q416$1.20$1.08$1.41 billion$1.3906 billionViewListenView Earnings Details
11/1/2016Q316$0.36$0.36$1.67 billion$1.64 billionViewN/AView Earnings Details
8/2/2016Q216$0.36$0.34$1.66 billion$1.6410 billionViewN/AView Earnings Details
5/3/2016Q1$0.25$0.28$1.55 billion$1.5975 billionViewN/AView Earnings Details
2/24/2016Q415$0.35$0.35$1.45 billion$1.4818 billionViewListenView Earnings Details
11/3/2015Q3 2015$0.91$0.99$643.74 million$650.23 millionViewN/AView Earnings Details
10/22/2015Q315$0.39$0.30$1.41 billion$1.37 billionViewListenView Earnings Details
8/4/2015Q215$0.35$0.37$1.30 billion$1.35 billionViewListenView Earnings Details
5/5/2015Q115$0.26$0.26$1.19 billion$1.24 billionViewN/AView Earnings Details
2/25/2015Q414$0.36$0.36$1.16 billion$1.16 billionViewN/AView Earnings Details
11/4/2014Q314$0.33$0.35$1.13 billion$1.1503 billionViewN/AView Earnings Details
7/31/2014Q214$0.25$0.28$1.04 billion$1.0753 billionViewN/AView Earnings Details
4/22/2014Q114$0.19$0.20$1.02 billion$1.0140 billionViewN/AView Earnings Details
3/5/2014Q413$0.17$0.20$994.41 million$984.80 millionViewN/AView Earnings Details
2/25/2014Q4 2013$0.57$0.60$282.97 million$284.57 millionViewN/AView Earnings Details
11/13/2013Q3 13$0.13$0.13$950.22 million$955.90 millionViewN/AView Earnings Details
10/22/2013Q3 2013$0.53$0.53$265.62 million$268.23 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.55$0.58$266.01 million$269.34 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.52$0.52$261.36 million$260.06 millionViewN/AView Earnings Details
2/25/2013Q4 2012$0.51$0.49ViewN/AView Earnings Details
10/23/2012Q3 2012$0.49$0.49ViewN/AView Earnings Details
7/24/2012Q2 2012$0.50$0.51ViewN/AView Earnings Details
4/24/2012Q1 2012$0.48$0.50ViewN/AView Earnings Details
2/23/2012Q4 2011$0.46$0.46ViewN/AView Earnings Details
10/25/2011Q3 2011$0.44$0.46ViewN/AView Earnings Details
7/21/2011Q2 2011$0.41$0.41ViewN/AView Earnings Details
4/21/2011Q1 2011$0.38$0.38ViewN/AView Earnings Details
2/24/2011Q4 2010$0.42$0.43ViewN/AView Earnings Details
10/21/2010Q3 2010$0.42$0.43ViewN/AView Earnings Details
7/22/2010Q2 2010$0.42$0.43ViewN/AView Earnings Details
4/22/2010Q1 2010$0.42$0.42ViewN/AView Earnings Details
2/24/2010Q4 2009$0.42$0.42ViewN/AView Earnings Details
10/22/2009Q3 2009$0.43$0.44ViewN/AView Earnings Details
7/23/2009Q2 2009$0.41$0.45ViewN/AView Earnings Details
4/23/2009Q1 2009$0.39$0.40ViewN/AView Earnings Details
2/19/2009Q4 2008$0.40$0.40ViewN/AView Earnings Details
10/23/2008Q3 2008$0.38$0.39ViewN/AView Earnings Details
7/22/2008Q2 2008$0.39$0.39ViewN/AView Earnings Details
4/22/2008Q1 2008$0.37$0.37ViewN/AView Earnings Details
2/19/2008Q4 2007$0.37$0.37ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Envision Healthcare (NYSE:EVHC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Envision Healthcare (NYSE EVHC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.10%
Insider Trading History for Envision Healthcare (NYSE:EVHC)
Insider Trading History for Envision Healthcare (NYSE:EVHC)

Envision Healthcare (NYSE EVHC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/3/2017Robert Jon CowardInsiderSell1,500$62.69$94,035.0097,863View SEC Filing  
6/22/2017Robert Jon CowardInsiderSell1,500$60.00$90,000.0099,363View SEC Filing  
5/3/2017Robert Jon CowardInsiderSell1,500$60.53$90,795.00114,363View SEC Filing  
4/3/2017Robert Jon CowardInsiderSell1,500$61.34$92,010.00115,863View SEC Filing  
3/10/2017John Thomas GawaluckDirectorBuy1,500$66.65$99,975.006,080View SEC Filing  
3/1/2017Robert Jon CowardInsiderSell1,500$65.00$97,500.00104,319View SEC Filing  
10/5/2015Leonard M Riggs JrDirectorSell4,000$36.24$144,960.0032,179View SEC Filing  
9/15/2015Randel G OwenCFOSell20,000$42.00$840,000.00367,683View SEC Filing  
9/14/2015William A. SangerCEOSell175,000$41.06$7,185,500.00View SEC Filing  
8/17/2015Randel G OwenCFOSell140,000$44.22$6,190,800.00View SEC Filing  
8/17/2015Todd G ZimmermanCEOSell180,000$44.21$7,957,800.00View SEC Filing  
7/6/2015Leonard M Riggs JrDirectorSell4,000$39.32$157,280.00View SEC Filing  
6/25/2015Dighton PackardInsiderSell40,000$40.00$1,600,000.00View SEC Filing  
4/20/2015Dighton PackardInsiderSell240,188$39.44$9,473,014.72View SEC Filing  
4/16/2015Horne Edward VanInsiderSell10,000$40.00$400,000.00View SEC Filing  
4/16/2015William A SangerCEOSell418,500$40.00$16,740,000.00View SEC Filing  
4/13/2015Craig A WilsonSVPSell18,600$39.57$736,002.00View SEC Filing  
4/13/2015Leonard M Riggs JrDirectorSell4,000$39.57$158,280.00View SEC Filing  
3/19/2015Horne Edward VanInsiderSell12,000$38.00$456,000.00View SEC Filing  
3/19/2015Randel G OwenCFOSell50,000$38.04$1,902,000.00View SEC Filing  
3/16/2015Richard J SchnallDirectorBuy100,000$36.73$3,673,000.00View SEC Filing  
3/9/2015Steven G MurphySVPSell12,021$36.03$433,116.63View SEC Filing  
2/25/2015William A SangerCEOSell153,782$37.50$5,766,825.00View SEC Filing  
2/23/2015William A SangerCEOSell7,100$37.54$266,534.00View SEC Filing  
1/9/2015William A SangerCEOSell194,968$37.52$7,315,199.36View SEC Filing  
1/8/2015Randel G OwenCFOSell200,000$36.56$7,312,000.00View SEC Filing  
10/31/2014Randel G OwenCFOSell19,180$35.00$671,300.00View SEC Filing  
10/28/2014Randel G OwenCFOSell30,820$35.00$1,078,700.00View SEC Filing  
10/24/2014Todd G ZimmermanCEOSell125,000$35.00$4,375,000.00View SEC Filing  
10/22/2014Horne Edward VanInsiderSell6,540$35.00$228,900.00View SEC Filing  
10/6/2014Horne Edward VanInsiderSell10,200$35.00$357,000.00View SEC Filing  
10/1/2014Horne Edward VanInsiderSell10,606$34.67$367,710.02View SEC Filing  
9/29/2014Dighton PackardInsiderSell32,400$34.97$1,133,028.00View SEC Filing  
9/29/2014Michael L SmithDirectorSell7,000$34.97$244,790.00View SEC Filing  
9/29/2014Randel G OwenCFOSell150,000$34.97$5,245,500.00View SEC Filing  
9/29/2014Steve W Ratton JrEVPSell25,000$34.97$874,250.00View SEC Filing  
9/29/2014William A SangerCEOSell200,000$34.97$6,994,000.00View SEC Filing  
9/15/2014Steven G MurphySVPSell45,988$34.75$1,598,083.00View SEC Filing  
7/16/2014Horne Edward VanInsiderSell20,269$32.90$666,850.10View SEC Filing  
7/16/2014Leonard M Riggs JrDirectorSell15,000$32.90$493,500.00View SEC Filing  
7/16/2014Randel G OwenCFOSell249,375$32.90$8,204,437.50View SEC Filing  
7/16/2014Steve W Ratton JrEVPSell42,948$32.90$1,412,989.20View SEC Filing  
7/16/2014Steven G MurphySVPSell21,852$32.90$718,930.80View SEC Filing  
7/16/2014William A SangerCEOSell543,900$32.90$17,894,310.00View SEC Filing  
8/19/2013Leonard M Riggs JrDirectorBuy44,000$23.00$1,012,000.00View SEC Filing  
8/19/2013Steven G MurphySVPBuy5,000$23.00$115,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Envision Healthcare (NYSE EVHC) News Headlines

Source:
DateHeadline
Envision Healthcare (EVHC) Receives Consensus Recommendation of "Hold" from AnalystsEnvision Healthcare (EVHC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 24 at 3:28 AM
Report: HCA makes offer to buy EnvisionReport: HCA makes offer to buy Envision
finance.yahoo.com - May 21 at 4:44 PM
HCA and KKR team up for Envision bid: SourcesHCA and KKR team up for Envision bid: Sources
www.cnbc.com - May 21 at 7:28 AM
Exclusive: HCA, KKR team up for Envision bid - sourcesExclusive: HCA, KKR team up for Envision bid - sources
www.reuters.com - May 19 at 8:54 AM
Envision Healthcare Infiltrated Americas ERs. Now Its Facing A BacklashEnvision Healthcare Infiltrated America's ERs. Now It's Facing A Backlash
finance.yahoo.com - May 15 at 9:28 AM
Zacks Investment Research Upgrades Envision Healthcare (EVHC) to BuyZacks Investment Research Upgrades Envision Healthcare (EVHC) to Buy
www.americanbankingnews.com - May 11 at 8:26 PM
SunTrust Banks Weighs in on Envision Healthcares FY2018 Earnings (EVHC)SunTrust Banks Weighs in on Envision Healthcare's FY2018 Earnings (EVHC)
www.americanbankingnews.com - May 11 at 10:52 AM
Envision Healthcare Increased on May 10Envision Healthcare Increased on May 10
finance.yahoo.com - May 11 at 9:42 AM
Research Analysts Set Expectations for Envision Healthcares Q2 2018 Earnings (EVHC)Research Analysts Set Expectations for Envision Healthcare's Q2 2018 Earnings (EVHC)
www.americanbankingnews.com - May 11 at 8:55 AM
Piper Jaffray Weighs in on Envision Healthcares Q2 2018 Earnings (EVHC)Piper Jaffray Weighs in on Envision Healthcare's Q2 2018 Earnings (EVHC)
www.americanbankingnews.com - May 11 at 8:54 AM
Thursday Sector Leaders: Healthcare, Technology & CommunicationsThursday Sector Leaders: Healthcare, Technology & Communications
www.nasdaq.com - May 10 at 5:05 PM
Edited Transcript of EVHC.N earnings conference call or presentation 8-May-18 12:30pm GMTEdited Transcript of EVHC.N earnings conference call or presentation 8-May-18 12:30pm GMT
finance.yahoo.com - May 10 at 5:05 PM
Envision Healthcare up 6% premarket on rumored KKR bidEnvision Healthcare up 6% premarket on rumored KKR bid
seekingalpha.com - May 10 at 9:10 AM
Q2 2018 Earnings Forecast for Envision Healthcare Issued By SunTrust Banks (EVHC)Q2 2018 Earnings Forecast for Envision Healthcare Issued By SunTrust Banks (EVHC)
www.americanbankingnews.com - May 10 at 6:54 AM
Envision Healthcare (EVHC) Price Target Raised to $48.00Envision Healthcare (EVHC) Price Target Raised to $48.00
www.americanbankingnews.com - May 9 at 6:09 PM
Envision Healthcare Breaks Above 200-Day Moving Average - Bullish for EVHCEnvision Healthcare Breaks Above 200-Day Moving Average - Bullish for EVHC
www.nasdaq.com - May 9 at 4:53 PM
Envision Healthcare (EVHC) Expected to Announce Quarterly Sales of $2.10 BillionEnvision Healthcare (EVHC) Expected to Announce Quarterly Sales of $2.10 Billion
www.americanbankingnews.com - May 9 at 2:00 AM
Envision Healthcare (EVHC) Q1 2018 Results - Earnings Call TranscriptEnvision Healthcare (EVHC) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 4:53 PM
Envision accuses insurers of tactics that fuel conflictEnvision accuses insurers of 'tactics that fuel conflict'
www.bizjournals.com - May 8 at 4:53 PM
Envision accuses insurers of 'tactics that fuel conflict'Envision accuses insurers of 'tactics that fuel conflict'
finance.yahoo.com - May 8 at 4:53 PM
 Analysts Anticipate Envision Healthcare (EVHC) Will Post Earnings of $0.64 Per Share Analysts Anticipate Envision Healthcare (EVHC) Will Post Earnings of $0.64 Per Share
www.americanbankingnews.com - May 7 at 9:14 PM
Envision Healthcare (EVHC) Announces  Earnings ResultsEnvision Healthcare (EVHC) Announces Earnings Results
www.americanbankingnews.com - May 7 at 8:50 PM
Envision Healthcare (EVHC) Issues FY18 Earnings GuidanceEnvision Healthcare (EVHC) Issues FY18 Earnings Guidance
www.americanbankingnews.com - May 7 at 5:30 PM
Envision Healthcare (EVHC) Updates Q2 Earnings GuidanceEnvision Healthcare (EVHC) Updates Q2 Earnings Guidance
www.americanbankingnews.com - May 7 at 5:30 PM
Envision Healthcare beats by $0.07, beats on revenueEnvision Healthcare beats by $0.07, beats on revenue
seekingalpha.com - May 7 at 4:59 PM
Envision Healthcare: 1Q Earnings SnapshotEnvision Healthcare: 1Q Earnings Snapshot
finance.yahoo.com - May 7 at 4:59 PM
Envision Healthcare Reports Solid Results for 2018 First QuarterEnvision Healthcare Reports Solid Results for 2018 First Quarter
finance.yahoo.com - May 7 at 4:59 PM
Contrasting Envision Healthcare (EVHC) & Concord Medical Services (CCM)Contrasting Envision Healthcare (EVHC) & Concord Medical Services (CCM)
www.americanbankingnews.com - May 7 at 11:24 AM
Should You Buy Envision Healthcare Corporation (NYSE:EVHC) Now?Should You Buy Envision Healthcare Corporation (NYSE:EVHC) Now?
finance.yahoo.com - May 7 at 8:56 AM
Teladoc (TDOC) versus Envision Healthcare (EVHC) Head to Head ComparisonTeladoc (TDOC) versus Envision Healthcare (EVHC) Head to Head Comparison
www.americanbankingnews.com - May 4 at 5:13 PM
Envision Healthcare Corporation -- Moodys upgrades Envision Healthcare Corporations senior secured term loan to Ba2 and affirms B1 CFR; outlook changed to stableEnvision Healthcare Corporation -- Moody's upgrades Envision Healthcare Corporation's senior secured term loan to Ba2 and affirms B1 CFR; outlook changed to stable
finance.yahoo.com - May 4 at 4:47 PM
Healthcare Stocks Earnings Due on May 7: EVHC, PINC & MoreHealthcare Stocks' Earnings Due on May 7: EVHC, PINC & More
finance.yahoo.com - May 4 at 8:58 AM
Healthcare Stocks' Earnings Due on May 7: EVHC, PINC & MoreHealthcare Stocks' Earnings Due on May 7: EVHC, PINC & More
finance.yahoo.com - May 4 at 8:58 AM
Envision Healthcare (EVHC) Stock Rating Lowered by ValuEngineEnvision Healthcare (EVHC) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - May 4 at 12:13 AM
Envision Healthcare (EVHC) Downgraded by Zacks Investment Research to HoldEnvision Healthcare (EVHC) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 1 at 2:02 PM
Will Cigna (CI) Beat Q1 Earnings Estimates This Time Again?Will Cigna (CI) Beat Q1 Earnings Estimates This Time Again?
www.msn.com - May 1 at 9:05 AM
Envision Healthcare (EVHC) to Release Quarterly Earnings on MondayEnvision Healthcare (EVHC) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - April 30 at 11:34 AM
Envision Healthcare (EVHC) Expected to Earn Q2 2018 Earnings of $0.85 Per ShareEnvision Healthcare (EVHC) Expected to Earn Q2 2018 Earnings of $0.85 Per Share
www.americanbankingnews.com - April 30 at 2:10 AM
Envision Healthcare (EVHC) Short Interest Up 15.1% in AprilEnvision Healthcare (EVHC) Short Interest Up 15.1% in April
www.americanbankingnews.com - April 30 at 2:04 AM
Envision Healthcare (EVHC) Given Consensus Recommendation of "Hold" by BrokeragesEnvision Healthcare (EVHC) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 29 at 3:24 AM
Envision sale narrowed to 3 bidders - DealreporterEnvision sale narrowed to 3 bidders - Dealreporter
seekingalpha.com - April 27 at 4:46 PM
Research Analysts Issue Forecasts for Envision Healthcares Q4 2018 Earnings (EVHC)Research Analysts Issue Forecasts for Envision Healthcare's Q4 2018 Earnings (EVHC)
www.americanbankingnews.com - April 27 at 9:38 AM
Notable Thursday Option Activity: BKNG, EVHC, REGNNotable Thursday Option Activity: BKNG, EVHC, REGN
www.nasdaq.com - April 26 at 4:46 PM
Chanos bearish on Envision and MednaxChanos bearish on Envision and Mednax
seekingalpha.com - April 26 at 8:53 AM
Reviewing Concord Medical Services (CCM) & Envision Healthcare (EVHC)Reviewing Concord Medical Services (CCM) & Envision Healthcare (EVHC)
www.americanbankingnews.com - April 24 at 7:24 PM
 Analysts Expect Envision Healthcare (EVHC) Will Post Quarterly Sales of $2.02 Billion Analysts Expect Envision Healthcare (EVHC) Will Post Quarterly Sales of $2.02 Billion
www.americanbankingnews.com - April 22 at 2:16 AM
Head-To-Head Comparison: Concord Medical Services (CCM) and Envision Healthcare (EVHC)Head-To-Head Comparison: Concord Medical Services (CCM) and Envision Healthcare (EVHC)
www.americanbankingnews.com - April 21 at 5:14 AM
Envision Healthcare (EVHC) Expected to Announce Earnings of $0.64 Per ShareEnvision Healthcare (EVHC) Expected to Announce Earnings of $0.64 Per Share
www.americanbankingnews.com - April 20 at 7:14 PM
Royal Bank of Canada Increases Envision Healthcare (EVHC) Price Target to $77.00Royal Bank of Canada Increases Envision Healthcare (EVHC) Price Target to $77.00
www.americanbankingnews.com - April 20 at 3:39 PM
Envision Healthcare (EVHC) Given "Buy" Rating at Cantor FitzgeraldEnvision Healthcare (EVHC) Given "Buy" Rating at Cantor Fitzgerald
www.americanbankingnews.com - April 19 at 10:46 PM

SEC Filings

Envision Healthcare (NYSE:EVHC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Envision Healthcare (NYSE:EVHC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Envision Healthcare (NYSE EVHC) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.